U.S. markets close in 5 hours 37 minutes
  • S&P 500

    3,877.05
    +31.97 (+0.83%)
     
  • Dow 30

    31,190.65
    +152.97 (+0.49%)
     
  • Nasdaq

    11,509.57
    +147.72 (+1.30%)
     
  • Russell 2000

    1,759.06
    +31.52 (+1.82%)
     
  • Crude Oil

    103.25
    +4.72 (+4.79%)
     
  • Gold

    1,746.80
    +10.30 (+0.59%)
     
  • Silver

    19.40
    +0.24 (+1.23%)
     
  • EUR/USD

    1.0173
    -0.0011 (-0.11%)
     
  • 10-Yr Bond

    2.9670
    +0.0540 (+1.85%)
     
  • GBP/USD

    1.1989
    +0.0067 (+0.56%)
     
  • USD/JPY

    135.7560
    -0.1590 (-0.12%)
     
  • BTC-USD

    20,673.68
    +534.96 (+2.66%)
     
  • CMC Crypto 200

    451.38
    +7.06 (+1.59%)
     
  • FTSE 100

    7,192.56
    +84.79 (+1.19%)
     
  • Nikkei 225

    26,490.53
    +382.88 (+1.47%)
     

Gracell Biotechnologies to Participate in Four Upcoming Investor Conferences

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

SUZHOU, China and PALO ALTO, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that it will participate in the following upcoming conferences:

Goldman Sachs Asia Pacific Healthcare Forum 2021

One-on-one and small group meetings (virtual): November 15-17, 2021

For more information, please contact your Goldman Sachs representative.

8th BioCentury-BayHelix China Healthcare Summit

In-person one-on-one and small group meetings (Shanghai, China): November 17, 2021

Panel - China Biotech CEO Blue Ribbon Roundtable: November 17, 2021, 14:30-15:15pm CST

For more information, please contact your Biocentury representative.

Jefferies London Healthcare Conference

One-on-one and small group meetings (virtual): November 18-19, 2021

Fireside Chat: available on-demand beginning on Thursday, November 18, 3:00am ET

Webcast link: https://ir.gracellbio.com/news-events/events-and-presentations

The replay of the fireside chat can be accessed through the “News and Events” section of the Gracell Investor website.

For more information, please contact your Jefferies representative.

20th Morgan Stanley Annual Asia Pacific Summit

One-on-one and small group meetings (virtual): November 18-19, 2021

For more information, please contact your Morgan Stanley representative.

About Gracell

Gracell Biotechnologies Inc. ("Gracell") is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies. Leveraging its pioneering FasTCAR and TruUCAR technology platforms, Gracell is developing a rich clinical-stage pipeline of multiple autologous and allogeneic product candidates with the potential to overcome major industry challenges that persist with conventional CAR-T therapies, including lengthy manufacturing time, suboptimal production quality, high therapy cost and lack of effective CAR-T therapies for solid tumors. For more information on Gracell, please visit www.gracellbio.com

Follow @GracellBio on LinkedIn

Media contact

Marvin Tang

marvin.tang@gracellbio.com

Investor contact

Gracie Tong

gracie.tong@gracellbio.com